Scilex Holding Co. (SCLX)
5.495
+0.06
(+1.20%)
USD |
NASDAQ |
Aug 31, 16:00
5.59
+0.10
(+1.73%)
After-Hours: 07:22
Scilex Total Liabilities (Quarterly) : 564.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 564.05M |
| March 31, 2026 | 547.70M |
| December 31, 2025 | 576.73M |
| September 30, 2025 | 455.60M |
| June 30, 2025 | 332.74M |
| March 31, 2025 | 290.46M |
| December 31, 2024 | 285.59M |
| September 30, 2024 | 311.75M |
| June 30, 2024 | 319.24M |
| March 31, 2024 | 281.03M |
| December 31, 2023 | 274.25M |
| September 30, 2023 | 243.20M |
| Date | Value |
|---|---|
| June 30, 2023 | 116.05M |
| March 31, 2023 | 74.98M |
| December 31, 2022 | 50.29M |
| September 30, 2022 | 12.17M |
| June 30, 2022 | 52.88M |
| March 31, 2022 | 11.10M |
| December 31, 2021 | 301.81M |
| September 30, 2021 | 10.09M |
| June 30, 2021 | 8.904M |
| March 31, 2021 | 8.832M |
| December 31, 2020 | 0.1808M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 52.17M |
| Semnur Pharmaceuticals, Inc. | 31.62M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.56M |
| Shareholders Equity (Quarterly) | -308.32M |
| Debt to Equity Ratio | -0.3437 |
| Current Ratio | 0.0707 |
| Net Debt Paydown Yield | -20.84% |